Marko Lens

3.7k total citations
53 papers, 2.5k citations indexed

About

Marko Lens is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Marko Lens has authored 53 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Marko Lens's work include Cutaneous Melanoma Detection and Management (26 papers), Immunotherapy and Immune Responses (10 papers) and Nonmelanoma Skin Cancer Studies (10 papers). Marko Lens is often cited by papers focused on Cutaneous Melanoma Detection and Management (26 papers), Immunotherapy and Immune Responses (10 papers) and Nonmelanoma Skin Cancer Studies (10 papers). Marko Lens collaborates with scholars based in United Kingdom, United States and Canada. Marko Lens's co-authors include Martin Dawes, Julia Newton‐Bishop, Véronique Bataille, Ljiljana Medenica, Tim Goodacre, Tim Eisen, Zoran Krivokapić, A P Boon, Tim D. Spector and Sandro Pasquali and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Marko Lens

52 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marko Lens United Kingdom 26 1.6k 756 507 479 433 53 2.5k
Manuel Martín González Spain 23 770 0.5× 843 1.1× 363 0.7× 487 1.0× 302 0.7× 115 2.1k
Uwe Hillen Germany 34 1.0k 0.6× 816 1.1× 381 0.8× 1.2k 2.5× 690 1.6× 136 3.8k
Klemens Rappersberger Austria 32 1.0k 0.6× 857 1.1× 410 0.8× 558 1.2× 1.6k 3.6× 123 3.7k
Lynn A. Cornelius United States 28 1.0k 0.7× 1.0k 1.4× 275 0.5× 350 0.7× 609 1.4× 72 3.0k
Priyadharsini Nagarajan United States 24 1.3k 0.8× 595 0.8× 551 1.1× 598 1.2× 390 0.9× 147 2.3k
Kee Yang Chung South Korea 31 874 0.6× 899 1.2× 665 1.3× 1.3k 2.6× 280 0.6× 211 3.5k
Karen Blessing United Kingdom 26 995 0.6× 595 0.8× 667 1.3× 433 0.9× 166 0.4× 71 2.1k
Heike Audring Germany 29 744 0.5× 440 0.6× 535 1.1× 1.3k 2.8× 1.1k 2.5× 90 3.1k
Giovanni Paolino Italy 21 444 0.3× 389 0.5× 406 0.8× 581 1.2× 356 0.8× 157 1.7k
Mirjana Ziemer Germany 23 547 0.3× 288 0.4× 355 0.7× 476 1.0× 260 0.6× 138 1.7k

Countries citing papers authored by Marko Lens

Since Specialization
Citations

This map shows the geographic impact of Marko Lens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Lens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Lens more than expected).

Fields of papers citing papers by Marko Lens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Lens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Lens. The network helps show where Marko Lens may publish in the future.

Co-authorship network of co-authors of Marko Lens

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Lens. A scholar is included among the top collaborators of Marko Lens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Lens. Marko Lens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lens, Marko & Jacob Schachter. (2025). Immune Checkpoint Inhibitors in the Treatment of Advanced Melanoma in Older Patients: An Overview of Published Data. Cancers. 17(11). 1835–1835. 1 indexed citations
2.
Lens, Marko. (2025). Phospholipid-Based Vesicular Systems as Carriers for the Delivery of Active Cosmeceutical Ingredients. International Journal of Molecular Sciences. 26(6). 2484–2484. 9 indexed citations
3.
Bataille, Véronique, Marko Lens, & Tim D. Spector. (2012). The use of the twin model to investigate the genetics and epigenetics of skin diseases with genomic, transcriptomic and methylation data. Journal of the European Academy of Dermatology and Venereology. 26(9). 1067–1073. 38 indexed citations
4.
McGrath, John A., Tanasit Techanukul, Gomathy Sethuraman, et al.. (2011). Novel and Recurrent FERMT1 Gene Mutations in Kindler Syndrome. Acta Dermato Venereologica. 91(3). 267–270. 19 indexed citations
5.
Lens, Marko. (2011). Recent Progresses in Application of Fullerenes in Cosmetics. Recent Patents on Biotechnology. 5(2). 67–73. 38 indexed citations
6.
Lens, Marko, et al.. (2009). Anterior Tab Flap Versus Standard Underlay Myringoplasty in Children. Otology & Neurotology. 30(6). 777–781. 24 indexed citations
7.
Lens, Marko, Véronique Bataille, & Zoran Krivokapić. (2009). Melanoma of the small intestine. The Lancet Oncology. 10(5). 516–521. 114 indexed citations
8.
Lens, Marko. (2009). Use of Fullerenes in Cosmetics. Recent Patents on Biotechnology. 3(2). 118–123. 55 indexed citations
9.
Lens, Marko, Stephan Bielfeldt, Véronique Bataille, & Klaus‐Peter Wilhelm. (2008). p53 labeling index in assessing the efficacy of a sunscreen in protection against UV‐induced damage. International Journal of Dermatology. 47(12). 1234–1239. 2 indexed citations
10.
Lens, Marko. (2008). The role of vaccine therapy in the treatment of melanoma. Expert Opinion on Biological Therapy. 8(3). 315–323. 15 indexed citations
11.
Lens, Marko & Véronique Bataille. (2008). Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues. Cancer Causes & Control. 19(5). 437–442. 65 indexed citations
12.
Lens, Marko, Pier Francesco Ferrucci, & Alessandro Testori. (2008). Anti-CTLA4 Monoclonal Antibody Ipilimumab in the Treatment of Metastatic Melanoma: Recent Findings. Recent Patents on Anti-Cancer Drug Discovery. 3(2). 105–113. 23 indexed citations
13.
Lens, Marko, et al.. (2008). Contact-diode laser repair of bony choanal atresia: A preliminary report. International Journal of Pediatric Otorhinolaryngology. 72(5). 625–628. 16 indexed citations
14.
Lens, Marko. (2006). Cutaneous melanoma: interferon alpha adjuvant therapy for patients at high risk for recurrent disease. Dermatologic Therapy. 19(1). 9–18. 18 indexed citations
15.
Lens, Marko & Julia Newton‐Bishop. (2005). An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review. Annals of Oncology. 16(3). 460–465. 47 indexed citations
16.
Lens, Marko, Julia Newton‐Bishop, & A P Boon. (2005). Desmoplastic malignant melanoma: a systematic review. British Journal of Dermatology. 152(4). 673–678. 105 indexed citations
17.
Lens, Marko, Tony Reiman, & Amna Husain. (2003). Use of tamoxifen in the treatment of malignant melanoma. Cancer. 98(7). 1355–1361. 50 indexed citations
18.
Lens, Marko, Martin Dawes, Tim Goodacre, & Julia Newton‐Bishop. (2002). Elective Lymph Node Dissection in Patients With Melanoma. Archives of Surgery. 137(4). 458–61. 60 indexed citations
19.
Lens, Marko, Martin Dawes, Julia Newton‐Bishop, & Tim Goodacre. (2002). Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy. British journal of surgery. 89(10). 1223–1227. 53 indexed citations
20.
Dawes, Martin & Marko Lens. (2002). Economic evaluation in evidence-based practice. Expert Opinion on Pharmacotherapy. 3(9). 1239–1243. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026